Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma
Clinical trial NCT06904170 · RECRUITING
Trial details
- NCT number
- NCT06904170
- Sponsor
- UNICANCER
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-14
- Primary completion
- 2029-09-14
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.